AVTR:NYSE
Avantor Inc
$15.39
arrow_upward
+0.26%(+0.040) 1D
$15.39
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 8, 4:00:06 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AVTR...
Open
$15.22
High
$15.42
Low
$14.96
Mkt. cap
10.41B
Avg. vol.
8.40M
Volume
12.13M
52-wk high
$16.38
52-wk low
$7.26
EPS
-$0.85
Beta
0.94
Shares outstanding
676.36M
No. of employees
14K
Open
$15.22
High
$15.42
Low
$14.96
Mkt. cap
10.41B
Avg. vol.
8.40M
Volume
12.13M
52-wk high
$16.38
52-wk low
$7.26
EPS
-$0.85
Beta
0.94
Shares outstanding
676.36M
No. of employees
14K
News stories
From web sources and news partners
MyChesCo
·
2 hours ago
Avantor Sets Oct. 28 for Third-Quarter Earnings Report
Zacks
·
8 hours ago
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
AD HOC NEWS
·
10 hours ago
Barclays raises target for Avantor stock from USD 13.00 to USD 15.00
Zacks
·
11 hours ago
Progyny (PGNY) Soars 6.3%: Is Further Upside Left in the Stock?
Profile
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”. Wikipedia
About Avantor Inc
CEOEmmanuel Ligner
Employees13.5K
Founded1904
HeadquartersRadnor Township, Pennsylvania, United States
SectorHealth care
Websiteavantorsciences.com